Neuroone Medical Technologies Corporation

NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement

NeuroOne(R) Announces Chief Financial Officer Succession Plan

NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time

NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance

NeuroOne(R) Medical Technologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)